100 Comparison of Warfarin Time in Therapeutic Range Before and After Home Meter Enrollment

100 Comparison of Warfarin Time in Therapeutic Range Before and After Home Meter Enrollment

Saved in:

Bibliographic Details
Main Authors:	Kaitlyn P. Coggsdale, PharmD, CPP, Sarah L.E. Russell, PharmD, BCACP, CPP, Mattlyn T. Staley, PharmD, CPP, Kristin D. Bradley, PharmD, BCPS, CPP, Anne M. Rodino, PharmD, BCCP, CPP
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925001116
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

128 Evaluation of Heparin-Induced Thrombocytopenia Testing to Improve Anticoagulation Stewardship in an Acute Care Setting
by: Yelena Samofalova, PharmD, et al.
Published: (2025-05-01)

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin
by: Mujtaba Mahmud PharmD, et al.
Published: (2025-08-01)

A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01)

Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
by: Maxwell Lamb, PharmD, BCPS, et al.
Published: (2025-06-01)

Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report
by: Kristin Waters, PharmD, BCPS, BCPP, et al.
Published: (2025-06-01)

191 Pharmacist Empowerment, Mandatory 4T Scoring and Real-time EHR Alerts to Optimize Antithrombosis Stewardship Around Diagnosis and Management of Heparin Induced Thrombocytopenia: The Persistent Study
by: Shruti N. Karanth, PharmD, et al.
Published: (2025-05-01)

Comparison of Direct Oral Anticoagulants for Treatment of Cerebral Venous Thrombosis – A Retrospective Cohort Study
by: Paul Phan PharmD, et al.
Published: (2025-01-01)

Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
by: Lama Alfehaid PharmD, MME, et al.
Published: (2025-08-01)

Re: Hernandez Bustamante et al. “Pharmacist administration of long-acting injectable medications for substance use disorders”
by: Jerry McKee, PharmD, MS, BCPP, et al.
Published: (2025-08-01)

Management of antidepressant-induced bruxism
by: Hayley Cliatt, PharmD, et al.
Published: (2025-06-01)

Trazodone versus doxepin as a pharmacologic sleep aid in psychiatric inpatients: A retrospective cohort study
by: Kevin Chen, PharmD, et al.
Published: (2025-04-01)

Two Is Better Than One: Clinical Assessments
by: Ahlam A. Ayyad PharmD, et al.
Published: (2025-04-01)

Memantine leading to physical aggression in the treatment of chronic catatonia secondary to schizophrenia: A case report
by: Andrew Chantha Hean, PharmD, et al.
Published: (2025-08-01)

Implementation of mMINDS monitoring for alcohol withdrawal at an inpatient academic psychiatric facility
by: Leah A. Surbaugh, PharmD, BCPP, et al.
Published: (2025-08-01)

Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01)

Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review
by: Eric P. Borrelli, PhD, PharmD, MBA, et al.
Published: (2025-06-01)

Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia
by: Abdulaali R. Almutairi PhD, et al.
Published: (2025-02-01)

Review of acamprosate pharmacokinetics and dosing strategies
by: Lauren Steil, PharmD, et al.
Published: (2025-04-01)

Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
by: Samantha Catanzano, PharmD, BCPP, et al.
Published: (2025-06-01)

Evaluation of workload among Board-Certified Psychiatric Pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, BCPP, FCCP, FASHP, et al.
Published: (2025-06-01)

Guanfacine for the management of the behavioral manifestations of delirium in older hospitalized adults
by: Kayla Garvey, PharmD, et al.
Published: (2025-06-01)

A primary care psychiatric pharmacist clinic for addressing hypertension and mental health disparities in black patients
by: Stephanie L. Hsia, PharmD, BCPP, MAEd, et al.
Published: (2025-08-01)

140 Impact of Amiodarone Exposure on Apixaban Pharmacokinetics in Hospitalized Patients
by: Samantha Kolowrat, BS, et al.
Published: (2025-05-01)

A potential case of refeeding syndrome in a patient with severe mental illness
by: Amber R. Douglass, PharmD, BCPS, BCPP, FAAPP, et al.
Published: (2025-08-01)

Exploring the Use of Mobile Health Applications in Palestinian Community Pharmacy Practice
by: Ahmed Nouri, PharmD, MSc
Published: (2025-01-01)

Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem
by: Adrian de Boer, PharmD, et al.
Published: (2025-07-01)

Impact of Extending Beta-Lactam Infusions on IV Access Requirements
by: Kirstin J. Kooda, PharmD, et al.
Published: (2025-08-01)

A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome
by: Monica Fahmy, PharmD, et al.
Published: (2025-04-01)

Evaluating a Community Health Worker Training Program for Medication Adherence Support
by: Richard Segal, RPh, PhD, et al.
Published: (2025-06-01)

Motivators and Barriers for Pursuing Postgraduate Programs in Pharmacy Practice Among Pharmacy Interns in Saudi Arabia
by: Abdullah M. Alhammad PharmD, et al.
Published: (2025-08-01)

Use of psychostimulants in the management of treatment-resistant major depressive disorder
by: Sara L. Pucci, PharmD, BCPP
Published: (2025-08-01)

Suicide risk identification and mitigation in patients with chronic pain prescribed opioid medication
by: Dana L. Chiulli, PharmD, BCPP
Published: (2024-12-01)

ERAS including minimal Narcotic Pain Management Is Successful After Heart Transplant and LVAD Implantation: A Single Center Review
by: Joseph Elder, PharmD BCPS, et al.
Published: (2025-08-01)

Developing personas to examine older adult engagement with televised direct-to-consumer advertisements: A theory based approach
by: Emily L. Hoffins, MS, et al.
Published: (2025-06-01)

Targeted lipid nanoparticles to modulate blood-brain barrier transcytosis in acute ischemic stroke
by: Jia Nong, Ph.D., et al.
Published: (2025-07-01)

Pharmacists’ Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey
by: Sibylle Frerebeau PharmD, et al.
Published: (2025-06-01)

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders
by: Anaïs Nombel, PharmD, et al.
Published: (2025-05-01)

Alternative methods for analyzing cross-sectional studies of common outcomes: A guide for healthcare professionals
by: Mohammad H. Aljawadi, BPharm, PharmD, MSc, PhD
Published: (2025-08-01)

The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention
by: Bryce A. Kiberd, MD, et al.
Published: (2025-05-01)

Patient and Cardiologist Perspectives on the Treatment of Patients With Concomitant ASCVD and Obesity
by: Pam Taub MD, et al.
Published: (2025-05-01)